Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PFE · against 24 other Healthcare companies of similar size
Ranked #11 of 25 · scores higher than 54% of peers
Bars: peers in each 10-point band of the valuation score7 peers with a valuation score of 60–69, including PFE · Click a bar to see the companies
Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | PFE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 25 reported | 2.6% | 3.8% | 17% | 30% | |
| EBITDA yieldHigher is better · 25 reported | 11.4% | 6.6% | 79% | 50% | |
| Free cash flow yieldHigher is better · 24 reported | 6.4% | 4.9% | 70% | 20% | |
| Book yieldHigher is better · 23 reported | 49.8% | 20.1% | 86% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 92 | 71 | |
| 2 | 108.6B USD | 88 | 66 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 126.1B USD | 83 | 62 | |
| 4 | 540.4B BRL (≈$97.3B) | 83 | 64 | |
| 8 | 89.7B USD | 76 | 50 | |
| 9 | 116.9B USD | 70 | 47 | |
| 10 | 302.7B USD | 68 | 63 | |
| 11 | 285.2B USD | 66 | 63 | |
| 11 | 171.0B USD | 66 | 45 | |
| 13 | 116.5B USD | 63 | 57 | |
| 14 | 84.5B EUR (≈$92.9B) | 62 | 51 | |
| 15 | 100.2B USD | 61 | 68 | |
| 16 | 249.4B USD | 60 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score